Per-Protocol Analyses of Pragmatic Trials
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Pragmatic trials are designed to address real-world questions about care options. This article addresses issues that may arise from per-protocol and intention-to-treat analyses of such trials, outlines alternative analytic approaches, and provides guidance on how to choose among them.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We developed a revised risk-of-bias assessment tool to address these issues, incorporate advances in assessment of risk of bias used in other recently developed tools, 9 10 and integrate recent developments in estimation of intervention effects from randomised trials. 11”
From RoB 2: a revised tool for assessing risk of bias in randomised trials (2019) · cites this paper as [11]
In the citing paper
“For trials comparing interventions that are sustained over time, appropriate methods also require measurement of and adjustment for the values of prognostic factors, both before and after randomisation, that predict deviations from intervention. 11”
From RoB 2: a revised tool for assessing risk of bias in randomised trials (2019) · cites this paper as [11]
In the citing paper
“Each effect might be of interest. 11”
From RoB 2: a revised tool for assessing risk of bias in randomised trials (2019) · cites this paper as [11]
In the citing paper
“RoB 2 also incorporates recent developments in estimation of intervention effects from randomised trials: we distinguish bias in the effect of assignment to interventions from bias in the effect of adhering to intervention as specified in the trial protocol.”
From RoB 2: a revised tool for assessing risk of bias in randomised trials (2019) · cites this paper as [11]
Citations
Cites
Marginal Structural Models and Causal Inference in Epidemiology
Robins, J. M., Hernán, M. Á., & Brumback, B. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00011 · Cited by 5,581
Self-citationRobins, J. (1986) · Mathematical Modelling · doi:10.1016/0270-0255(86)90088-6 · Cited by 2,451
Self-citationRosenbaum, P. R. (2002) · Springer Series in Statistics · doi:10.1007/978-1-4757-3692-2 · Cited by 2,394
Doubly robust estimation in missing data and causal inference models
Bang, H., & Robins, J. M. (2005) · Biometrics · doi:10.1111/j.1541-0420.2005.00377.x · Cited by 1,998
Self-citationIntention-to-treat concept: A review
Gupta, S. (2011) · Perspectives in Clinical Research · doi:10.4103/2229-3485.83221 · Cited by 1,921
The prevention and treatment of missing data in clinical trials
Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmsr1203730 · Cited by 1,884
Why Most Discovered True Associations Are Inflated
Ioannidis, J. P. A. (2008) · Epidemiology · doi:10.1097/ede.0b013e31818131e7 · Cited by 1,495
An introduction to instrumental variables for epidemiologists
Greenland, S. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.4.722 · Cited by 1,156
Instruments for Causal Inference: An Epidemiologist's Dream?
Hernán, M. A., & Robins, J. M. (2006) · Epidemiology · doi:10.1097/01.ede.0000222409.00878.37 · Cited by 961
Self-citationRobins, J. M., & Finkelstein, D. M. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00779.x · Cited by 877
Self-citation
Cited by
Items 501–600 of 661
Keele, L. J., & Grieve, R. (2021) · Clinical Trials · doi:10.1177/17407745211056881 · Cited by 1
“Several recent articles have highlighted the limitations of an intentionto-treat analysis.(10,11) Specifically, intention-to-treat estimates may be an underestimate in safety trials or overestimate effectiveness when treatment is compared to an active control as is true in REFLUX.”
BackgroundMethodPhillips, P. P. J., & Glidden, D. V. (2022) · Springer eBooks · doi:10.1007/978-3-319-52636-2_98 · Cited by 2
Statistical Basic Steps to Be Considered on Planning a Research
Camargo, C. P., & Gemperli, R. (2018) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000001718 · Cited by 1
Alternatives to Intention-to-Treat Analyses
Geldsetzer, P., Bärnighausen, T., & Sudharsanan, N. (2019) · JAMA · doi:10.1001/jama.2019.3092 · Cited by 1
Stress Ulcer Prophylaxis for ICU Patients
Torres, C. M., & Navarrete, S. (2020) · JAMA · doi:10.1001/jama.2020.6762 · Cited by 1
Vicarious Dissonance : Meta-analysisPreprint
Jaubert, S., Fillon, A. A., Souchet, L., & Girandola, F. (2020) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/hc2n3 · Cited by 3
Management of childhood functional constipation in primary care
van Summeren, J. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.210773134 · Cited by 1
Perkin, M. R., Bahnson, H. T., & Lack, G. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.01.015 · Cited by 1
Samago, A. (2023) · Preprints.org · doi:10.20944/preprints202312.1826.v1 · Cited by 1
Therapeutic-Dose Anticoagulation in Hospitalized Patients With COVID-19
Berg, D. D. (2024) · JACC Advances · doi:10.1016/j.jacadv.2023.100779 · Cited by 1
Beyond superiority: preserved cardiovascular efficacy and emerging signals in SURPASS-CVOT
Corrao, S., & Federici, M. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02673-w · Cited by 1
“…such as dual incre - tin agonists, this may involve complementing traditional MACE endpoints with outcomes that better reflect systemic vulnerability, including all-cause mortality, recurrent-event frameworks, and multistate models integrating heart failure, renal decline, and death [7 – 9].”
To stop or not to stop: a value of information view
Siebert, U., & Hallsson, L. R. (2018) · European Journal of Epidemiology · doi:10.1007/s10654-018-0432-6
Atrial fibrillation ablation after the CABANA study: beyond statistical dogma
Roca‐Luque, I., Tolosana, J. M., & Brugada, J. (2020) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2020.07.014
O’Brien, K. S. (2020) · eScholarship (California Digital Library)
Sensitivity analyses in pragmatic randomized clinical trials
Suarez, E. A., & Girman, C. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817663-4.00029-5
Approaches to mitigate bias in the design and analysis of pRCTs
Raman, S. R., Landi, S. N., Lund, J. L., & Funk, M. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817663-4.00021-0
Treatment for hyperkalaemia in heart failure: a network meta-analysis
Chong, N. J., Yamamoto, S., & Wong, R. C.-C. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014770
Causal Inference in Health Services Research
Madenci, A. L. (2020) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
1. Single-lumen Tube 挿管による気管膜様部裂傷の 1 例(第 24 回日本気管支学会東北支部会)
大杉, 純., 塚田, 学., 樫村, 省., 山下, 方., 鈴木, 弘., 藤生, 浩., 管野, 隆., & 後藤, 満. (1998) · 気管支学 : 日本気管支研究会雑誌
Commentary on Instrumental Variable Methods for Low CompliancePreprint
Shrier, I., Stokes, T., & Steele, R. J. (2021) · doi:10.31236/osf.io/ve4na
Quantifying Treatment Effects Using Randomized Trials
Newman, T. B., & Kohn, M. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108500111.009
Sidani, S., & Braden, C. J. (2021) · Wiley eBooks · doi:10.1002/9781119610113.ch15
Scheim, D. E., Dancis, J., & Aldous, C. M. (2022) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/xfbh3
Statistical Analysis Plan for the SMART Mental Health studyPreprint
Ghosh, A., Billot, L., Daniel, M., Maulik, P. K., & Peiris, D. (2022) · doi:10.31219/osf.io/96w5c
Keller, S., Tschan, F., Semmer, N. K., Trelle, S., Manser, T., & Beldi, G. (2022) · Research Square · doi:10.21203/rs.3.rs-1653398/v1
Randomized controlled trials of biomarker targets
Erlendsdottir, M., & Crawford, F. W. (2022) · Clinical Trials · doi:10.1177/17407745221131820
“Unfortunately, these two trials of the same targets may not be comparable because of differences in the physician population, even when the biological effect of active treatment is the same.(2,43) While any two randomized trials may be difficult to compare due to differences in inclusion criteria and study protocols,…”
BackgroundYin, J., Li, Y., Wang, C., Qin, C., & Miao, M. (2023) · doi:10.2196/preprints.46323
Coffman, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823026-8.00064-x
On the Current State of Privacy Risks in Software Requirement Elicitation Techniques
Saeed, Z., Haider, S., Ali, Z., Arshad, M., & Alam, I. (2023) · Advances in information security, privacy, and ethics book series · doi:10.4018/978-1-6684-6914-9.ch008
Targeted Oxygen Therapy in Adult Intensive Care Unit Patients
Klitgaard, T. (2022) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau473635979
Tools for determination of food allergy in epidemiological studies
Peters, R. L., Soriano, V. X., Wijesuriya, R., & Koplin, J. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96018-2.00046-8
Prognostic and treatment effect modeling in medical research
Hoogland, J. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/1789 · Cited by 1
Evaluating the Effectiveness of Daily Self-Weighing to Prevent Age-Related Weight GainPreprint
Levitsky, D. A., Zhong, Y., Barré, L. K., & Mizia, A. C. (2023) · Research Square · doi:10.21203/rs.3.rs-2923764/v1
Early intervention for high risk smoldering multiple myeloma (SMM)
Chen, P., Jhou, H., Ho, C., Huang, H.-L., & Lee, C. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015494
Comments on ”Emerging insights and commentaries – MMRM vs LOCF by Naitee Ting”
Wright, D. N. M., Bratton, D. J., Drury, T., Keene, O. N., Rehal, S., & White, I. R. (2023) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2023.2250853
“The hypothetical strategy has close links to the causal inference literature, and the importance of estimating causal effects in clinical trials has been emphasised by Hernán and Robins (Hernán and Robins 2017).”
BackgroundPATCHing Traumatic Hemorrhage With Out-of-Hospital Tranexamic Acid Administration
Wilhelm, K., & Toy, J. (2023) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2023.09.011
Unresolved issues with noninferiority pragmatic trials: Results of a literature survey
Ciarleglio, M. M., Li, J., & Peduzzi, P. N. (2023) · Clinical Trials · doi:10.1177/17407745231206371
“23 Herna´n and Robins 20 also advocate, ‘‘the appropriate design, conduct and analysis of pragmatic trials requires an explicit and careful definition of the effect of interest.’’”
BackgroundXie, Y., & Al‐Aly, Z. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00292-9
Automated Insulin Delivery in Women With Pregnancy Complicated by Type 1 Diabetes
Lee, T., Collett, C., Bergford, S., Hartnell, S., SCOTT, E. M., Lindsay, R. S., Hunt, K. F., McCance, D. R., Barnard-Kelly, K. D., Rankin, D., et al. (2024) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0001016664.40824.26
An Invitation to Causal Inference in Environmental PsychologyPreprint
Bulbulia, J. A., & Hine, D. W. (2024) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/tbjx8
Placebo Adherence as a Negative Control Exposure
Wanis, K. N., & Sarvet, A. L. (2024) · Epidemiology · doi:10.1097/ede.0000000000001759
“3,6,7 These authors urged investigators not to abandon “per-protocol” effects, arguably their original target of inference.”
Vicarious Dissonance: Pre-Registered Meta-Analysis
Jaubert, S., Fillon, A. A., Souchet, L., & Girandola, F. (2024) · Personality and Social Psychology Bulletin · doi:10.1177/01461672241266653 · Cited by 1
“…et al., 2019) analysis, with an estimate of the per-protocol effect, or the effect of adherence to interventions as specified in the trial protocol (Hernán & Robins, 2017), covering 5 different types of biases (i.e., bias arising from the randomization process, bias due to deviations from intended…”
Kopp, L. H. P., Søgaard-Hansen, C. M., Zachhau, K. M., Bastkjær, R. M., Andersen, B. V., Budtz–Jørgensen, E., Byrne, D. V., Chaaban, N., Holst, J. J., Klindt, T., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-084686
“Per-protocol (PP) analyses 36 will be conducted to evaluate the diet effect on glucometabolic outcomes including the change in HbA 1c , body weight and hepatic fat content.”
MethodSafa, B., McHardy, P. G., & Choi, S. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.10.026
Peer Group Support to Children and Adolescents with HIV: A Randomized Controlled Trial in Vietnam
Abbasi, A., Toàn, T. K., Nguyen, C. T. K., Nguyen, L. V., Du, Q. T., Lê, N. N. T., Chau, V., Nguyen, L. T. M., Khuong, D. K., Olson, L., et al. (2026) · AIDS and Behavior · doi:10.1007/s10461-026-05204-4
Huang, B., Chen, C., Weldge, J., Wang, W., & DelBello, M. P. (2024) · Springer eBooks · doi:10.1007/978-3-031-65948-5_10
Souza, A. D., & Marinho, A. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-91790-2.00002-2
Altawil, A., Lauseker, M., & Mansmann, U. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5124889
Siriteerathitikul, P., Kunyalue, M., Yaowapankul, Y., Pudpong, P., Chantaramanee, N., Bootsikeaw, S., & Srisookkum, T. (2025) · Journal of Acupuncture and Tuina Science · doi:10.1007/s11726-025-1482-4
“Additionally, a limitation of this randomized trial is the potential bias introduced by dropouts in the per-protocol analysis [22] .”
Liu, L., Jiang, C., & Zhao, H. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.03.055
Estimating the Local Average Treatment Effect Without the Exclusion Restriction
Markovich, Z. (2025) · Political Analysis · doi:10.1017/pan.2025.10005
“The weighted per-protocol estimator proposed in the context of medical trials can also be understood as an example of principal score methods (Hernán and Robins 2017; Robins and Finkelstein 2000).”
Baumeister, A., Schuurmans, L., & Moritz, S. (2025) · Internet Interventions · doi:10.1016/j.invent.2025.100867 · Cited by 1
“We did not adjust for biases due to differential loss to follow-up for the PP analysis and therefore the validity of the effect estimates is limited (Hern ´ an and Robins, 2017).”
Blais, J. E., Yan, V. K. C., Chan, E. W., Wong, I. C. K., & Wan, E. Y. F. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119521
Cerebral Embolic Protection during TAVI
Kharbanda, R. K., Kennedy, J., & Dodd, M. (2025) · New England Journal of Medicine · doi:10.1056/nejmc2510558
Estimating per-protocol effects in external comparator analyses using real-world data
Gupta, A., Merinopoulou, E., Duffield, S. J., Gomes, M., Kent, S., Scheuer, N., Machnicki, G., & Sanglier, T. (2025) · Journal of Comparative Effectiveness Research · doi:10.57264/cer-2025-0029
“…of the PP effect and its estimation, how it differs from the ‘naive’ PP analysis reported by some RCTs, as well its application to observational analysis of real-world databases, we found only one prior study [16] so far that has attempted to operationalize its use in ECA studies [17–19] .”
Harri, A., Magder, L. S., Franklin, P. D., Magaziner, J. S., Kernan, L. M., Lambourne, C. A., & Pellegrini, V. D. (2025) · JBJS Open Access · doi:10.2106/jbjs.oa.25.00116 · Cited by 1
Jaber, S., Huguet, H., Molinari, N., & JONG, A. D. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-100149
“32 Secondary analyses An analysis of variance or Kruskal-Wallis test (as appropriate) will be used for continuous variables.”
Núñez, I., Rodríguez-Olivares, J. L., Díaz, J. A., & Caro-Vega, Y. N. (2025) · International Journal of Epidemiology · doi:10.1093/ije/dyaf178
Du, R., Li, J., Zhu, J., Chan, M. Y., & Tai, B. C. (2025) · Trials · doi:10.1186/s13063-025-09203-z · Cited by 1
“PP has been used as an alternative approach to address the issues that may arise from solely relying on the ITT principle [33].”
Bea, S., Huybrechts, K. F., Glynn, R. J., Vine, S. M., Belitkar, S., Bateman, B. T., & Bykov, K. (2025) · BMC Medicine · doi:10.1186/s12916-025-04475-3
“We estimated both the observational analog of the per-protocol (on-treatment) effect [24], defined as the effect of adherence to the treatment strategy with concomitant use, and the 60-day intention-to-treat effect, defined as the effect of SSRI initiation while on hydrocodone, in parallel.”
Morán, J., Duarte, J., Zapata, J., Alkabes-Esquenazi, L., González, S., Solervicens, P., Klagges, M., Díaz, F., Marcelo Arancibia, M., García, F., et al. (2025) · F1000Research · doi:10.12688/f1000research.169442.1
Rozema, L. R., Murray, E. J., Watts, B. V., Gui, J., Gradus, J. L., & Shiner, B. R. (2025) · Journal of Dual Diagnosis · doi:10.1080/15504263.2025.2603711
“To address these, we employed inverse propensity weighting wherein patients are weighted based on the inverse of their probability of receiving the treatment they were given (IPTW), having complete follow-up (IPCW), and adhering (IPAW) respectively (Hernán & Robins, 2017).”
Merlo, C., Essig, S., Brancati-Badarau, D. O., Leuppi, J. D., Speich, B., Erlanger, T. E., Hemkens, L. G., & Zeller, A. (2020) · Figshare · doi:10.6084/m9.figshare.13279131
Hills, N. K., Lyimo, J., Nahid, P., Savic, R. M., Lienhardt, C., & Phillips, P. P. J. (2021) · Figshare · doi:10.6084/m9.figshare.15102600
Thriemer, K., Degaga, T. S., Christian, M., Alam, M. S., Ley, B., Hossain, M. S., Kibria, M. G., Tego, T. T., Abate, D. T., Weston, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19793511
Deshpande, A., Walker, R. E., Schulte, R. J., Pallotta, A. M., Tereshchenko, L. G., Hu, B., Kadri, S. S., Klompas, M., & Rothberg, M. B. (2023) · Figshare · doi:10.6084/m9.figshare.24152475
Massol, J., Simon‐Tillaux, N., Tohme, J., Hariri, G., Dureau, P., Duceau, B., Belin, L., Hajage, D., Rycke, Y. D., Charfeddine, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26567192
Favaretti, C., Pillai, V. S., Murthy, S., Chandrasekar, A., Yan, S. D., Sulaiman, H., Gautam, A., Kaur, B., Ali, M. K., McConnell, M. A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26966406
Favaretti, C., Pillai, V. S., Murthy, S., Chandrasekar, A., Yan, S. D., Sulaiman, H., Gautam, A., Kaur, B., Ali, M. K., McConnell, M. A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26966409
Merlo, C., Essig, S., Brancati-Badarau, D. O., Leuppi, J. D., Speich, B., Erlanger, T. E., Hemkens, L. G., & Zeller, A. (2020) · Figshare · doi:10.6084/m9.figshare.13279134
Martínez‐González, M. Á., Montero, P., Ruiz‐Canela, M., Toledo, E., Estruch, R., Gómez‐Gracia, E., Li, J., Ros, E., Arós, F., Hernáez, Á., et al. (2023) · Figshare · doi:10.6084/m9.figshare.26621056
Coll‐Planas, L., Carbó, A., Jansson, A., Dostálová, V., Bártová, A., Rautiainen, L. J., Kolster, A., Masó-Aguado, M., Briones‐Buixassa, L., Alias, S. B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26667280
Merlo, C., Essig, S., Brancati-Badarau, D. O., Leuppi, J. D., Speich, B., Erlanger, T. E., Hemkens, L. G., & Zeller, A. (2020) · Figshare · doi:10.6084/m9.figshare.13279137
Lerche, A. F., Mathiassen, S. E., Rasmussen, C. L., Straker, L. M., Søgaard, K., & Holtermann, A. (2022) · Figshare · doi:10.6084/m9.figshare.19227085
Coll‐Planas, L., Carbó, A., Jansson, A., Dostálová, V., Bártová, A., Rautiainen, L. J., Kolster, A., Masó-Aguado, M., Briones‐Buixassa, L., Alias, S. B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26667274
Coll‐Planas, L., Carbó, A., Jansson, A., Dostálová, V., Bártová, A., Rautiainen, L. J., Kolster, A., Masó-Aguado, M., Briones‐Buixassa, L., Alias, S. B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26667283
Fernández, A. I., Bermejo, J., Yotti, R., Martínez‐González, M. Á., Mira, A., Gophna, U., Karlsson, R., Al‐Daccak, R., Martín-Demiguel, I., Gutiérrez, E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17004429
Kjeldsted, E., Ammitzbøll, G., Jørgensen, L. B., Lodin, A., Bojesen, R. D., Ceballos, S. G., Rosthøj, S., Lænkholm, A.-V., Skou, S. T., Jack, S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23994551
Martínez‐González, M. Á., Montero, P., Ruiz‐Canela, M., Toledo, E., Estruch, R., Gómez‐Gracia, E., Li, J., Ros, E., Arós, F., Hernáez, Á., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26621065
Thriemer, K., Degaga, T. S., Christian, M., Alam, M. S., Ley, B., Hossain, M. S., Kibria, M. G., Tego, T. T., Abate, D. T., Weston, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19793508
Weir, I. R., Dufault, S. M., & Phillips, P. P. J. (2024) · Figshare · doi:10.6084/m9.figshare.25389448
Msellemu, D. F., Ross, A., Temu, L., Moshi, I., Hofer, L. M., Mwanziva, C. E., Kohi, Y. M., & Moore, S. J. (2021) · Figshare · doi:10.6084/m9.figshare.17058702
Weir, I. R., Dufault, S. M., & Phillips, P. P. J. (2024) · Figshare · doi:10.6084/m9.figshare.25389958
Keller, S., Tschan, F., Semmer, N. K., Trelle, S., Manser, T., & Beldi, G. (2022) · Figshare · doi:10.6084/m9.figshare.21359873
Additional file 1 of Per-protocol analysis of the ZINC trial for HIV disease among alcohol users
Lodi, S., Freiberg, M. S., Gnatienko, N., Blokhina, E. A., Yaroslavtseva, T., Krupitsky, E., Murray, E. J., Samet, J. H., & Cheng, D. M. (2021) · Figshare · doi:10.6084/m9.figshare.14274762
Martínez‐González, M. Á., Montero, P., Ruiz‐Canela, M., Toledo, E., Estruch, R., Gómez‐Gracia, E., Li, J., Ros, E., Arós, F., Hernáez, Á., et al. (2023) · Figshare · doi:10.6084/m9.figshare.26621062
Thriemer, K., Degaga, T. S., Christian, M., Alam, M. S., Ley, B., Hossain, M. S., Kibria, M. G., Tego, T. T., Abate, D. T., Weston, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19793505
Martínez‐González, M. Á., Montero, P., Ruiz‐Canela, M., Toledo, E., Estruch, R., Gómez‐Gracia, E., Li, J., Ros, E., Arós, F., Hernáez, Á., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26621059
Bosco, E., Riester, M. R., Beaudoin, F. L., Schoenfeld, A. J., Gravenstein, S., Mor, V., & Zullo, A. R. (2024) · Figshare · doi:10.6084/m9.figshare.25556515
Fernández, A. I., Bermejo, J., Yotti, R., Martínez‐González, M. Á., Mira, A., Gophna, U., Karlsson, R., Al‐Daccak, R., Martín-Demiguel, I., Gutiérrez, E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17004432
Coll‐Planas, L., Carbó, A., Jansson, A., Dostálová, V., Bártová, A., Rautiainen, L. J., Kolster, A., Masó-Aguado, M., Briones‐Buixassa, L., Alias, S. B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26667286
Weir, I. R., Dufault, S. M., & Phillips, P. P. J. (2024) · Figshare · doi:10.6084/m9.figshare.26692090
Avoiding methodological pitfalls in assessing cardiovascular and thromboembolic risk in dermatology
Poizeau, F., & Droitcourt, C. (2026) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.70177
“In such settings, pragmatic approaches include censoring fol- low-up at discontinuation (a per-protocol strategy), 8 modelling exposure as time-varying to reflect treatment changes, or using flexible parametric models that accommodate varying exposure patterns.”
Jabbari, K., & Kaoutzanis, C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-91168-9.00093-4
Intraoperative Blood Pressure and Delirium: Fuzzy Questions and Fuzzy Answers
Bokoch, M. P., & Whitlock, E. L. (2026) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000007946
Shi, X., Wang, X., & Guo, J.-R. (2026) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.12.013
A comprehensive set of per-protocol analyses of the myocardial ischemia and transfusion (MINT) trial
Herbert, B. M., Carson, J. L., Bertolet, M. H., Alexander, J. H., Goodman, S. G., Fergusson, D. A., Ducrocq, G., Lópes, R. D., Simon, T., Steg, P. G., et al. (2026) · American Heart Journal · doi:10.1016/j.ahj.2026.107382
Ribeiro, D. C., Lamb, S. E., & Abbott, J. H. (2026) · Arthritis Care & Research · doi:10.1002/acr.80021
“24,26 27 Through inverse-probability weighting, we created a pseudopo-pulation pseudopo-pulation in which Moderation analysis.”
Dahal, T. (2026) · Southeast Asian Journal of Case Report and Review · doi:10.18231/j.sajcrr.70236.1771670233
Corticosteroids and antiviral treatment for Bell's palsy (idiopathic facial paralysis)
Kurotschka, P. K., Daly, F., Gágyor, I., Bauer, M., Babl, F. E., Santiago, V. H., Bassi, M. C., Somasundara, D., Lowe, S. W., & Sullivan, F. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015563 · Cited by 1
“We intend to quantify the effect of assignment to the interventions at baseline, regardless of whether the interventions are received as intended (the intention-to-treat effect) [48].”
Metadata
- Authors
- Hernán, M. A., & Robins, J. M.
- Affiliations
- Harvard University (US)
- ORCID
- Robins, James M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-10-05
- Volume
- 377
- Issue
- 14
- Pages
- 1391-1398
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2764336450
- Cited by
- 660
- References
- 32
- Citations by year
- 2026: 98 · 2025: 89 · 2024: 95 · 2023: 74 · 2022: 82 · 2021: 79 · 2020: 73 · 2019: 39 · 2018: 26 · 2017: 3
- FWCI
- 26.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Keywords
- pragmatic trials, per-protocol analysis, intention-to-treat analysis, real-world evidence, treatment effect estimation
- MeSH terms
- Clinical Protocols, Data Interpretation, Statistical, Humans, Patient Compliance, Research Design, Intention to Treat Analysis, Pragmatic Clinical Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.